Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

QMG4, LLC

NPI: 1023471299 · BRIDGEPORT, CT 06606 · Family Medicine Physician · NPI assigned 04/04/2016

$3.30M
Total Medicaid Paid
103,971
Total Claims
90,006
Beneficiaries
33
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialHEFFER, STEVEN (OWNER/MEDICAL DIRECTOR)
NPI Enumeration Date04/04/2016

Related Entities

Other providers sharing the same authorized official: HEFFER, STEVEN

ProviderCityStateTotal Paid
QUENTIN MEDICAL GROUP, LLC BRIDGEPORT CT $9.27M
QMG2,LLC FAIRFIELD CT $2.21M
QMG3, LLC SHELTON CT $1.01M
QMG5,LLC TRUMBULL CT $328K
QMG7,LLC NEW HAVEN CT $236K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 12,446 $496K
2019 14,539 $579K
2020 12,190 $399K
2021 39,099 $999K
2022 13,628 $401K
2023 8,631 $295K
2024 3,438 $130K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 14,021 12,051 $1.12M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 9,221 8,251 $524K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 16,721 15,119 $493K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 3,857 3,435 $319K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 2,442 2,072 $285K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 3,272 2,924 $127K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 5,743 5,058 $104K
99051 16,666 15,326 $97K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 1,437 1,344 $92K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 7,731 3,626 $72K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 3,460 3,209 $32K
99201 326 301 $12K
36415 Collection of venous blood by venipuncture 2,716 2,454 $8K
81025 765 714 $4K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 211 151 $2K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 67 60 $709.11
71046 Radiologic examination, chest; 2 views 47 42 $699.66
99173 102 92 $608.76
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 80 60 $454.30
90674 39 36 $334.02
87807 14 12 $113.41
86580 13 12 $67.56
99000 11,644 10,524 $11.26
81003 1,758 1,617 $10.70
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 37 31 $4.18
85018 20 15 $2.03
90686 21 20 $0.00
G8484 Influenza immunization was not administered, reason not given 1,036 976 $0.00
G8482 Influenza immunization administered or previously received 230 216 $0.00
J7510 Prednisolone oral, per 5 mg 25 25 $0.00
G8483 Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) 183 177 $0.00
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) 28 28 $0.00
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 38 28 $0.00